DXCM

Dexcom Inc

• Seeking Alpha·5d ago

  DexCom: The Growth Thesis Still Needs To Be Proven

• Simply Wall St·06/30 09:16

  Did FDA-Backed Stelo Expansion Beyond Insulin Users Just Shift DexCom's (DXCM) Investment Narrative?

• Simply Wall St·06/28 23:12

  Is DexCom (DXCM) A Bargain On FDA Cleared Stelo Expansion?

• Seeking Alpha·06/28 13:05

  Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus

• Simply Wall St·06/27 00:18

  DexCom (DXCM) Launches New Stelo App As It Expands Into Four Countries

• NASDAQ·06/26 12:35

  Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

• TipRanks·06/23 16:10

  DexCom announces milestones to make glucose biosensing more accessible

• Seeking Alpha·06/23 15:23

  DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff

• Benzinga·06/23 13:47

  This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

• Dow Jones·06/23 13:32

  DexCom Price Target Announced at $86.00/Share by Deutsche Bank

• Benzinga·06/23 13:21

  Deutsche Bank Initiates Coverage On DexCom with Buy Rating, Announces Price Target of $86

• TipRanks·06/23 13:19

  DexCom initiated with a Buy at Deutsche Bank

• PUBT·06/23 13:01

  Dexcom wins FDA clearance for Stelo glucose biosensor use in children 2 and older

• Reuters·06/23 13:00

  DEXCOM FURTHER ADVANCES VISION OF GLUCOSE BIOSENSING FOR ALL

• Reuters·06/23 11:03

  DEXCOM INC <DXCM.O>: DEUTSCHE BANK INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $86